carbamazepine has been researched along with Amentia in 32 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of long-term consequences of lithium, valproic acid, carbamazepine and antipsychotic agents on the development of dementia or cognitive impairments in patients with bipolar disorder were investigated." | 9.41 | [Effects of lithium, valproic acid, carbamazepine and antipsychotic agents on cognition in bipolar disorders-A systematic review]. ( Leopold, S; Quante, A, 2023) |
| "To evaluate the efficacy of oxcarbazepine (OXC) in the treatment of agitation and aggression in patients with Alzheimer's disease, vascular dementia or both." | 9.14 | Effect of oxcarbazepine in the treatment of agitation and aggression in severe dementia. ( Aga, O; Cvancarova, M; Engedal, K; Olsen, IC; Selbaek, G; Sommer, OH, 2009) |
| "The aim of this study was to assess the effects of withdrawal from placebo and carbamazepine administered for agitation associated with dementia and to assess safety, tolerability, and efficacy of subsequent ongoing carbamazepine therapy." | 9.09 | Withdrawal from controlled carbamazepine therapy followed by further carbamazepine treatment in patients with dementia. ( Cox, C; Erb, R; Irvine, C; Jakimovich, LJ; Lanning, B; Podgorski, CA; Tariot, PN, 1999) |
| "The efficacy, safety, and tolerability of carbamazepine in the treatment of agitation and aggression associated with dementia were assessed." | 9.08 | Efficacy and tolerability of carbamazepine for agitation and aggression in dementia. ( Cox, C; Erb, R; Irvine, C; Jakimovich, L; Patel, S; Podgorski, CA; Tariot, PN, 1998) |
| "To determine the effects of carbamazepine versus placebo on ratings of behavior in agitated nursing home patients with dementia." | 9.07 | Carbamazepine treatment of agitation in nursing home patients with dementia: a preliminary study. ( Asnis, J; Cox, C; Erb, R; Irvine, C; Kolassa, J; Leibovici, A; Podgorski, CA; Tariot, PN, 1994) |
| " Controlled trials in elderly patients with epilepsy demonstrate efficacy and tolerability comparable to gabapentin." | 8.84 | Lamotrigine therapy in elderly patients with epilepsy, bipolar disorder or dementia. ( Nanry, K; Ramsay, E; Sajatovic, M; Thompson, T, 2007) |
| "Carbamazepine was administered in an open pilot study to 13 patients with primary degenerative dementia characterized by aggressive and assaultive behavior refractory to conventional treatment." | 7.67 | A preliminary study of carbamazepine in the treatment of assaultive patients with dementia. ( Patterson, JF, 1988) |
| "The effects of long-term consequences of lithium, valproic acid, carbamazepine and antipsychotic agents on the development of dementia or cognitive impairments in patients with bipolar disorder were investigated." | 5.41 | [Effects of lithium, valproic acid, carbamazepine and antipsychotic agents on cognition in bipolar disorders-A systematic review]. ( Leopold, S; Quante, A, 2023) |
| "Treatment with carbamazepine was evaluated in an open study design in 29 gerontopsychiatric inpatients." | 5.29 | [Therapeutic use of carbamazepine for treatment of agitation and affective disorders in geriatric psychiatry patients]. ( Lemke, MR; Stuhlmann, W, 1994) |
| "Dementia is an ailment that is becoming a major management problem." | 5.27 | Carbamazepine in dementia. ( Essa, M, 1986) |
| "To evaluate the efficacy of oxcarbazepine (OXC) in the treatment of agitation and aggression in patients with Alzheimer's disease, vascular dementia or both." | 5.14 | Effect of oxcarbazepine in the treatment of agitation and aggression in severe dementia. ( Aga, O; Cvancarova, M; Engedal, K; Olsen, IC; Selbaek, G; Sommer, OH, 2009) |
| "The aim of this study was to assess the effects of withdrawal from placebo and carbamazepine administered for agitation associated with dementia and to assess safety, tolerability, and efficacy of subsequent ongoing carbamazepine therapy." | 5.09 | Withdrawal from controlled carbamazepine therapy followed by further carbamazepine treatment in patients with dementia. ( Cox, C; Erb, R; Irvine, C; Jakimovich, LJ; Lanning, B; Podgorski, CA; Tariot, PN, 1999) |
| "The efficacy, safety, and tolerability of carbamazepine in the treatment of agitation and aggression associated with dementia were assessed." | 5.08 | Efficacy and tolerability of carbamazepine for agitation and aggression in dementia. ( Cox, C; Erb, R; Irvine, C; Jakimovich, L; Patel, S; Podgorski, CA; Tariot, PN, 1998) |
| "To determine the effects of carbamazepine versus placebo on ratings of behavior in agitated nursing home patients with dementia." | 5.07 | Carbamazepine treatment of agitation in nursing home patients with dementia: a preliminary study. ( Asnis, J; Cox, C; Erb, R; Irvine, C; Kolassa, J; Leibovici, A; Podgorski, CA; Tariot, PN, 1994) |
| " The purpose of this review of the literature is to assess the interest and the limits of anticonvulsant mood stabilizers (carbamazepine, valproic acid, gabapentin, lamotrigine, topiramate, oxcarbazepine) in the treatment of the so-called "noncognitive" symptoms of dementia." | 4.84 | [Anticonvulsant mood stabilizers in the treatment of behavioral and psychological symptoms of dementia (BPSD)]. ( Pinheiro, D, 2008) |
| " Controlled trials in elderly patients with epilepsy demonstrate efficacy and tolerability comparable to gabapentin." | 4.84 | Lamotrigine therapy in elderly patients with epilepsy, bipolar disorder or dementia. ( Nanry, K; Ramsay, E; Sajatovic, M; Thompson, T, 2007) |
| "To review and summarize the currently available data on the use of anticonvulsant mood stabilizers (carbamazepine, valproic acid, gabapentin, lamotrigine, topiramate) in the treatment of behavioral and psychological symptoms of dementia (BPSD); to determine whether these medications can be recommended for routine clinical use." | 4.84 | Anticonvulsants for the treatment of behavioral and psychological symptoms of dementia: a literature review. ( Konovalov, S; Muralee, S; Tampi, RR, 2008) |
| " In epilepsy after trauma, levetiracetam had the highest retention rate at 80% (95% confidence interval [CI] = 65-89), exceeding that of the most commonly prescribed ASM, carbamazepine (p = ." | 4.02 | Potential for improved retention rate by personalized antiseizure medication selection: A register-based analysis. ( Garcia-Ptacek, S; Håkansson, S; Karlander, M; Larsson, D; Mahamud, Z; Zelano, J; Zelezniak, A, 2021) |
| "Carbamazepine was administered in an open pilot study to 13 patients with primary degenerative dementia characterized by aggressive and assaultive behavior refractory to conventional treatment." | 3.67 | A preliminary study of carbamazepine in the treatment of assaultive patients with dementia. ( Patterson, JF, 1988) |
| "The phenytoin treatment causes cerebellar defect and anemia." | 2.82 | The interplay of epilepsy with impaired mitophagy and autophagy linked dementia (MAD): A review of therapeutic approaches. ( Agrawal, M; Dhurandhar, Y; Panda, SP, 2022) |
| " Although few studies are available, extrapolations from research in young people and elderly patients without dementia provide several recommendations for the management of seizures in patients with dementia: exclude symptomatic causes of seizures before committing to antiepileptic drug therapy; treat after a first seizure if there is evidence of focal neurological involvement or a risk of recurrent seizures; use antiepileptic drugs with minimal cognitive adverse effects, such as carbamazepine, valproic acid, gabapentin and lamotrigine; and use the lowest possible dosage and monitor antiepileptic drug levels, where possible." | 2.42 | Seizures in elderly patients with dementia: epidemiology and management. ( Lim, G; Mendez, M, 2003) |
| "Dementia affects 5% of persons over age 65 years and 20% of those over 80 years of age and is expected to increase further in the primary care setting as the population ages." | 2.39 | Management of the behavioral manifestations of dementia. ( Farnett, LE; Ruzicka, SA; Yeager, BF, 1995) |
| "The carbamazepine studies were inconclusive." | 2.38 | Nonneuroleptic treatment of disruptive behavior in organic mental syndromes. ( Perry, PJ; Smith, DA, 1992) |
| "We report on a 50-year-old man with mental retardation and right-sided hemi-paresis." | 1.32 | [Atypical epilepsy symptomatology as cause of a dementia like state in a mentally and physically retarded patient]. ( Huber, B; Seidel, M; Tomka-Hoffmeister, M, 2004) |
| "Treatment with carbamazepine was evaluated in an open study design in 29 gerontopsychiatric inpatients." | 1.29 | [Therapeutic use of carbamazepine for treatment of agitation and affective disorders in geriatric psychiatry patients]. ( Lemke, MR; Stuhlmann, W, 1994) |
| "Dementia is an ailment that is becoming a major management problem." | 1.27 | Carbamazepine in dementia. ( Essa, M, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (12.50) | 18.7374 |
| 1990's | 12 (37.50) | 18.2507 |
| 2000's | 10 (31.25) | 29.6817 |
| 2010's | 3 (9.38) | 24.3611 |
| 2020's | 3 (9.38) | 2.80 |
| Authors | Studies |
|---|---|
| Panda, SP | 1 |
| Dhurandhar, Y | 1 |
| Agrawal, M | 1 |
| Leopold, S | 1 |
| Quante, A | 1 |
| Håkansson, S | 1 |
| Karlander, M | 1 |
| Larsson, D | 1 |
| Mahamud, Z | 1 |
| Garcia-Ptacek, S | 1 |
| Zelezniak, A | 1 |
| Zelano, J | 1 |
| Vilibić, M | 1 |
| Jukić, V | 1 |
| Vidović, A | 1 |
| Brecić, P | 1 |
| Meyer, JM | 1 |
| Cummings, MA | 1 |
| Proctor, G | 1 |
| Stahl, SM | 1 |
| Pinheiro, D | 1 |
| Sommer, OH | 1 |
| Aga, O | 1 |
| Cvancarova, M | 1 |
| Olsen, IC | 1 |
| Selbaek, G | 1 |
| Engedal, K | 1 |
| Yeh, YC | 1 |
| Ouyang, WC | 1 |
| Gaber, TA | 1 |
| Eshiett, M | 1 |
| Mendez, M | 1 |
| Lim, G | 1 |
| Tomka-Hoffmeister, M | 1 |
| Huber, B | 1 |
| Seidel, M | 1 |
| Freymann, N | 1 |
| Michael, R | 1 |
| Dodel, R | 1 |
| Jessen, F | 1 |
| Horvath, J | 1 |
| Coeytaux, A | 1 |
| Jallon, P | 1 |
| Landis, T | 1 |
| Temperli, P | 1 |
| Burkhard, PR | 1 |
| Sajatovic, M | 1 |
| Ramsay, E | 1 |
| Nanry, K | 1 |
| Thompson, T | 1 |
| Hollis, J | 1 |
| Grayson, D | 1 |
| Forrester, L | 1 |
| Brodaty, H | 1 |
| Touyz, S | 1 |
| Cumming, R | 1 |
| Konovalov, S | 1 |
| Muralee, S | 1 |
| Tampi, RR | 1 |
| Tariot, PN | 4 |
| Frederiksen, K | 1 |
| Erb, R | 4 |
| Leibovici, A | 2 |
| Podgorski, CA | 4 |
| Asnis, J | 2 |
| Cox, C | 4 |
| Yeager, BF | 1 |
| Farnett, LE | 1 |
| Ruzicka, SA | 1 |
| Lemke, MR | 1 |
| Stuhlmann, W | 1 |
| Kolassa, J | 1 |
| Irvine, C | 3 |
| Mowadat, HR | 1 |
| Kerr, EE | 1 |
| StClair, D | 1 |
| Mintzer, JE | 1 |
| Brawman-Mintzer, O | 1 |
| Gertz, HJ | 1 |
| Göhringer, K | 1 |
| Schimmelpfennig, C | 1 |
| Patel, S | 1 |
| Jakimovich, L | 1 |
| Jakimovich, LJ | 1 |
| Lanning, B | 1 |
| Jokelainen, M | 1 |
| Schneider, LS | 1 |
| Sobin, PB | 1 |
| Smith, DA | 1 |
| Perry, PJ | 1 |
| Risse, SC | 1 |
| Barnes, R | 1 |
| Essa, M | 1 |
| Patterson, JF | 1 |
| Nicholson, WJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Oxcarbazepine in the Treatment of Agitation / Aggression in Dementia (OBAD) - An Eight Week Prospective, Randomized, Double-Blind, Placebo-Controlled, Multi Center Trial. A Phase III Study[NCT00145691] | Phase 3 | 100 participants | Interventional | 2005-09-30 | Completed | ||
| Levetiracetam for Alzheimer's Disease Neuropsychiatric Symptoms Related to Epilepsy Trial (LAPSE) - A Phase II Exploratory Study[NCT04004702] | Phase 2 | 65 participants (Anticipated) | Interventional | 2020-01-31 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
13 reviews available for carbamazepine and Amentia
| Article | Year |
|---|---|
The interplay of epilepsy with impaired mitophagy and autophagy linked dementia (MAD): A review of therapeutic approaches.
Topics: Anticonvulsants; Carbamazepine; Dementia; Epilepsy; Felbamate; Gabapentin; Humans; Inflammasomes; La | 2022 |
[Effects of lithium, valproic acid, carbamazepine and antipsychotic agents on cognition in bipolar disorders-A systematic review].
Topics: Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Cognition; | 2023 |
Psychopharmacology of Persistent Violence and Aggression.
Topics: Aggression; Antimanic Agents; Antipsychotic Agents; Brain Injuries, Traumatic; Carbamazepine; Clozap | 2016 |
[Anticonvulsant mood stabilizers in the treatment of behavioral and psychological symptoms of dementia (BPSD)].
Topics: Aged; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Dementia; Fructose; Gabap | 2008 |
Mood stabilizers for the treatment of behavioral and psychological symptoms of dementia: an update review.
Topics: Antipsychotic Agents; Carbamazepine; Dementia; Humans; Lamotrigine; Oxcarbazepine; Triazines; Valpro | 2012 |
Seizures in elderly patients with dementia: epidemiology and management.
Topics: Aged; Anticonvulsants; Carbamazepine; Case Management; Dementia; Epilepsy; Humans | 2003 |
Lamotrigine therapy in elderly patients with epilepsy, bipolar disorder or dementia.
Topics: Aged; Aged, 80 and over; Amines; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; | 2007 |
Anticonvulsants for the treatment of behavioral and psychological symptoms of dementia: a literature review.
Topics: Aggression; Amines; Anticonvulsants; Carbamazepine; Cognition Disorders; Cyclohexanecarboxylic Acids | 2008 |
Management of the behavioral manifestations of dementia.
Topics: Adrenergic beta-Antagonists; Anti-Anxiety Agents; Antipsychotic Agents; Carbamazepine; Clinical Tria | 1995 |
Agitation as a possible expression of generalized anxiety disorder in demented elderly patients: toward a treatment approach.
Topics: Aged; Aggression; Antipsychotic Agents; Anxiety Disorders; Behavior Therapy; Buspirone; Carbamazepin | 1996 |
Non-neuroleptic treatment of behavioral symptoms and agitation in Alzheimer's disease and other dementia.
Topics: Adrenergic beta-Antagonists; Alzheimer Disease; Buspirone; Carbamazepine; Dementia; Humans; Lithium; | 1992 |
Nonneuroleptic treatment of disruptive behavior in organic mental syndromes.
Topics: Adrenergic beta-Antagonists; Antisocial Personality Disorder; Autistic Disorder; Carbamazepine; Deme | 1992 |
Pharmacologic treatment of agitation associated with dementia.
Topics: Affective Symptoms; Aged; Aggression; Alzheimer Disease; Anti-Anxiety Agents; Antipsychotic Agents; | 1986 |
5 trials available for carbamazepine and Amentia
| Article | Year |
|---|---|
Effect of oxcarbazepine in the treatment of agitation and aggression in severe dementia.
Topics: Aged; Aged, 80 and over; Aggression; Alzheimer Disease; Anticonvulsants; Carbamazepine; Dementia; De | 2009 |
Lack of carbamazepine toxicity in frail nursing home patients: a controlled study.
Topics: Aged; Aged, 80 and over; Carbamazepine; Comorbidity; Cross-Over Studies; Dementia; Double-Blind Meth | 1995 |
Carbamazepine treatment of agitation in nursing home patients with dementia: a preliminary study.
Topics: Aged; Aged, 80 and over; Carbamazepine; Cross-Over Studies; Dementia; Female; Homes for the Aged; Hu | 1994 |
Efficacy and tolerability of carbamazepine for agitation and aggression in dementia.
Topics: Aged; Aged, 80 and over; Aggression; Alzheimer Disease; Carbamazepine; Dementia; Dementia, Vascular; | 1998 |
Withdrawal from controlled carbamazepine therapy followed by further carbamazepine treatment in patients with dementia.
Topics: Aggression; Anticonvulsants; Brief Psychiatric Rating Scale; Carbamazepine; Dementia; Drug Administr | 1999 |
14 other studies available for carbamazepine and Amentia
| Article | Year |
|---|---|
Potential for improved retention rate by personalized antiseizure medication selection: A register-based analysis.
Topics: Anticonvulsants; Brain Injuries, Traumatic; Carbamazepine; Dementia; Epilepsy; Humans; Levetiracetam | 2021 |
Cobalamin deficiency manifested with seizures, mood oscillations, psychotic features and reversible dementia in the absence of typical neurologic and hematologic signs and symptoms: a case report.
Topics: Carbamazepine; Dementia; Diazepam; Electroencephalography; Haloperidol; Hematology; Humans; Hydroxoc | 2013 |
Resolution of psychiatric symptoms secondary to herpes simplex encephalitis.
Topics: Anticonvulsants; Carbamazepine; Dementia; Encephalitis, Herpes Simplex; Encephalomalacia; Female; Fo | 2003 |
[Atypical epilepsy symptomatology as cause of a dementia like state in a mentally and physically retarded patient].
Topics: Anticonvulsants; Carbamazepine; Dementia; Electroencephalography; Epilepsy; Humans; Intellectual Dis | 2004 |
Successful treatment of sexual disinhibition in dementia with carbamazepine -- a case report.
Topics: Aged; Anticonvulsants; Carbamazepine; Dementia; Humans; Male; Sexual Dysfunction, Physiological; Tre | 2005 |
Carbamazepine encephalopathy masquerading as Creutzfeldt-Jakob disease.
Topics: Aged; Amines; Analgesics, Non-Narcotic; Atrophy; Basal Ganglia; Brain; Brain Damage, Chronic; Carbam | 2005 |
Antipsychotic medication dispensing and risk of death in veterans and war widows 65 years and older.
Topics: Age Factors; Aged; Aged, 80 and over; Anticonvulsants; Antipsychotic Agents; Australia; Benzodiazepi | 2007 |
[Therapeutic use of carbamazepine for treatment of agitation and affective disorders in geriatric psychiatry patients].
Topics: Aged; Carbamazepine; Dementia; Dose-Response Relationship, Drug; Drug Administration Schedule; Femal | 1994 |
Sporadic Pick's disease in a 28-year-old woman.
Topics: Adult; Atrophy; Carbamazepine; Dementia; Electroconvulsive Therapy; Female; Frontal Lobe; Haloperido | 1993 |
[Successful carbamazepine therapy of 2 cases of music hallucinations].
Topics: Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Dementia; Female; Hallucinations; Humans; M | 1996 |
[Dementia and carbamazepine medication in an elderly man].
Topics: Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Dementia; Epilepsy; Humans; Hyponatremia; M | 1998 |
Carbamazepine in dementia.
Topics: Antipsychotic Agents; Carbamazepine; Dementia; Humans; Male; Middle Aged | 1986 |
A preliminary study of carbamazepine in the treatment of assaultive patients with dementia.
Topics: Aged; Aggression; Carbamazepine; Dementia; Dose-Response Relationship, Drug; Drug Administration Sch | 1988 |
Medicine in old age. Disturbances of the special senses and other functions.
Topics: Aged; Carbamazepine; Deafness; Dementia; Epilepsy; Female; Geriatrics; Headache; Hematoma, Subdural; | 1974 |